Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation-Reference-Cited by-同舟云学术

Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation

Published:2022-05 Issue: Volume:Volume 16 Page:1201-1211
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Costa Gil José Esteban^ORCID,Garnica Cuéllar Juan Carlos^ORCID,Perez Terns Paula,Ferreira-Hermosillo Aldo^ORCID,Cetina Canto José Antonio^ORCID,Garduño Perez Ángel Alfonso,Mendoza Martínez Pedro,Rista Lucas,Sosa-Caballero Alejandro,Vázquez-Méndez Estefanía,Tejado Gallegos Luis Fernando,Chen Hungta,Elizalde Agustina,Tomatis Virginia B^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference34 articles.

1. Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme

2. Diabetes in South and Central America: An update

3. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

4. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent

5. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium; 2021. Available from: https://www.diabetesatlas.org/. Accessed March 11, 2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

2. Identifying patient preferences for diabetes care: A protocol for implementing a discrete choice experiment in Samoa;PLOS ONE;2023-12-22